Literature DB >> 25114451

The action of prostaglandins on ciliary hypertrichosis: a case report of pachydermoperiostosis.

Fabiana P Zarur1, Luiza Vf d'Almeida1, Anna Beatriz C Novellino1, Maria Fernanda Dg Reis1.   

Abstract

Pachydermoperiostosis or primary hypertropic osteoarthropathy is a rare hereditary disorder that was first described in 1868. It is characterized by digital clubbing, pachydermia (thickening of the facial skin and/or scalp), and periostosis (swelling of periarticular tissue and subperiosteal new bone formation). We report a case of a patient with the complete form of the disease, and with a unique appearance of the hair shaft and eyelashes. The authors propose a possible mechanism to justify the abnormalities observed in the patient's hair shafts regarding the metabolism of prostaglandins and its relationship with the hair follicle physiological cycle.

Entities:  

Keywords:  Cutis verticis gyrata; eyelashes; hair; pachydermoperiostosis; primary hypertrophic osteoarthropathy; prostaglandins

Year:  2014        PMID: 25114451      PMCID: PMC4124691          DOI: 10.4103/0974-7753.136756

Source DB:  PubMed          Journal:  Int J Trichology        ISSN: 0974-7753


INTRODUCTION

Pachydermoperiostosis or primary hypertropic osteoarthropathy is a rare hereditary disorder that was first described in 1868. It is characterized by digital clubbing, pachydermia and periostosis.[12] Touraine et al. described three forms of pachydermoperiostosis: (1) A complete form with pachydermia and periostosis, (2) an incomplete form with evidence of bone abnormalities but lacking pachydermia, and (3) a forme frusta with prominent pachydermia and minimal-to-absent skeletal changes.[34] We describe a case of a patient with the complete form of the syndrome, focusing on the changes in the hair and eyelashes. The authors suggest a possible mechanism for the observed changes.

CASE REPORT

A 22-year-old male patient, reports 5 years ago the initial development of facial skin thickening with accentuation of the ruts, pustules and cystic lesions on the face, and palmoplantar hyperhidrosis. Physical examination revealed thickening of facial skin with accentuated skin ruts and circumvolutions mainly in the frontal region and scalp (cutis verticis gyrata), presence of dense and voluminous hair, keloid scars, hypertrophic eyelid skin, and lengthened eyelashes [Figures 1 and 2]. The joint examination revealed digital clubbing of the hands and feet, and knees with swelling and joint effusion.
Figure 1

Thickening of facial skin with accentuated skin ruts and circumvolutions mainly in the frontal region, keloid scars, hypertrophic eyelid skin and lengthened eyelashes

Figure 2

Hypertrophic eyelid skin and lengthened eyelashes

Thickening of facial skin with accentuated skin ruts and circumvolutions mainly in the frontal region, keloid scars, hypertrophic eyelid skin and lengthened eyelashes He had radiographs showing diffuse periosteal thickening. Laboratorial exams were normal. Based on clinical and radiological findings, age of onset of the disease, and absence of underlying illnesses, the diagnosis of the full form of pachydermoperiostosis was established. Hypertrophic eyelid skin and lengthened eyelashes

DISCUSSION

The pathogenesis of pachydermoperiostosis involves the Human Gene and Protein Database mutation, gene that encodes the 15-hydroxyprostaglandin dehydrogenase, a key enzyme responsible for the degradation of prostaglandins (PGs).[56] Individuals with this mutation show high levels of PGs, especially PG E2 (PGE2). The clinical manifestations are due to the excessive formation of collagen by fibroblast hyperactivation promoted by PGE2. We believe that, in this case, the changes of the scalp hair and eyelashes can also be attributed to high levels of PG. Side-effects as cilliary hypertrichosis and eyelid hypertrophy, were observed in patients with topical PG analogues for glaucoma treatment.[7] This encouraged studies about their action in the hair follicle, and are currently approved by the Food and Drug Administration for the treatment of alopecia and cilliary hypotrichosis. The mechanism by which these drugs induce hypertrichosis is not totally elucidated, but experimental studies with rats have shown how they interfere in the hair cycle.[89] Receptors for PGE2 and F2α are described in hair follicles, especially in the follicular papilla.[10] They induce telogen follicles to enter the anagen phase early, in addition to promoting an extension of the same, delaying the onset of catagen phase. Other effects consist in follicular melanogenesis and thickening of the hair bulb, which leads to hyperpigmentation and hair thickening.[89] Thus longer, pigmented and thicker hair would have been noticed, which could explain the findings in this patient. We believe that in this case, the abnormalities found in the hair of the scalp and eyelashes can be attributed to high levels of prostaglandins present in patients with pachydermoperiostosis. There are no studies to corroborate that this mechanism can be applied to the hair of the scalp. However the clinical findings in this case favor this hypothesis.
  9 in total

1.  PACHYDERMOPERIOSTOSIS (IDIOPATHIC CLUBBING AND PERIOSTOSIS): GENETIC AND PHYSIOLOGIC CONSIDERATIONS.

Authors:  D L RIMOIN
Journal:  N Engl J Med       Date:  1965-05-06       Impact factor: 91.245

2.  Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost.

Authors:  M Tauchi; T A Fuchs; A J Kellenberger; D F Woodward; R Paus; E Lütjen-Drecoll
Journal:  Br J Dermatol       Date:  2010-03-12       Impact factor: 9.302

3.  Pachydermoperiostosis: the complete form of the syndrome.

Authors:  Marina Besen Guerini; Mariana Tremel Barbato; Naiana Bittencourt de Sá; Daniel Holthausen Nunes; Paulo Roberto Zeni
Journal:  An Bras Dermatol       Date:  2011 May-Jun       Impact factor: 1.896

4.  Primary hypertrophic osteoarthropathy.

Authors:  Hadi Poormoghim; Aref Hosseynian; Aryan Javadi
Journal:  Rheumatol Int       Date:  2010-12-02       Impact factor: 2.631

5.  Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model.

Authors:  S Sasaki; Y Hozumi; S Kondo
Journal:  Exp Dermatol       Date:  2005-05       Impact factor: 3.960

6.  Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases.

Authors:  Takaiko Yoshino; Takeo Fukuchi; Tetsuya Togano; Masaaki Seki; Hiroko Ikegaki; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2012-12-04       Impact factor: 2.447

7.  Prostaglandin E2 and bone turnover markers in the evaluation of primary hypertrophic osteoarthropathy (pachydermoperiostosis): a case report.

Authors:  A Martínez-Ferrer; P Peris; Ll Alós; M Morales-Ruiz; N Guañabens
Journal:  Clin Rheumatol       Date:  2009-05-21       Impact factor: 2.980

8.  Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy.

Authors:  Sandeep Uppal; Christine P Diggle; Ian M Carr; Colin W G Fishwick; Mushtaq Ahmed; Gamal H Ibrahim; Philip S Helliwell; Anna Latos-Bieleńska; Simon E V Phillips; Alexander F Markham; Christopher P Bennett; David T Bonthron
Journal:  Nat Genet       Date:  2008-05-25       Impact factor: 38.330

9.  Prostaglandin metabolism in human hair follicle.

Authors:  Laurent Colombe; Armelle Vindrios; Jean-François Michelet; Bruno Alain Bernard
Journal:  Exp Dermatol       Date:  2007-09       Impact factor: 3.960

  9 in total
  1 in total

1.  Pachydermoperiostosis in a Patient with Crohn's Disease: Treatment and Literature Review.

Authors:  Maryam Mobini; Ozra Akha; Hafez Fakheri; Hadi Majidi; Sanam Fattahi
Journal:  Iran J Med Sci       Date:  2018-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.